Drug and Therapeutics Bulletin 1998;36:73-76; doi:10.1136/dtb.1998.361073
Copyright © 1998 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

The place of pneumococcal vaccination

Relevant BNF section: 14.4

Vaccination against pneumococcal infection was introduced in the UK in 1979. Currently, the vaccine is recommended by the Department of Health for patients at high risk of developing pneumococcal infection.1 Here we discuss the epidemiology of pneumococcal infection and consider the effectiveness of the vaccines available and their use in clinical practice.




This article has been cited by other articles:


Home page
Eur Respir JHome page
R. Pistelli, P. Lange, and D.L. Miller
Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity
Eur. Respir. J., May 1, 2003; 21(40_suppl): 10S - 14s.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. W.-L. Soh, C. L. Poh, and R. V. T. P. Lin
Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates from Pediatric Patients in Singapore
Antimicrob. Agents Chemother., August 1, 2000; 44(8): 2193 - 2196.
[Abstract] [Full Text]



About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1998 BMJ Publishing Group Ltd.